Search

Search Funnelback University

Search powered by Funnelback
10 results 20 results 50 results
Relevance Date (Newest first) Date (Oldest first) Title (A-Z) Title (Z-A) Distance URL (A-Z) URL (Z-A) Shuffle
1 - 10 of 176 search results for KaKaoTalk:vb20 200 |u:www.enterprise.cam.ac.uk where 0 match all words and 176 match some words.

  1. Results that match 1 of 2 words

  2. CORFO Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/corfo/feed/
    26 Jun 2024: protecting the environment, building economies and enhancing the quality of life for users on a global scale.span data-ccp-props="{"201341983":0,"335559739":200,"335559740":276}"/span/p p ... product or service that meets market needs is often a step too

  3. Gyroscope Therapeutics: Acquisition by Novartis accelerates gene…

    https://www.enterprise.cam.ac.uk/case-studies/gyroscope-therapeutics-acquisition-by-novartis-accelerates-gene-therapy-for-ocular-diseases-towards-the-clinic/
    Thumbnail for Gyroscope Therapeutics: Acquisition by Novartis accelerates gene therapy for ocular diseases towards the clinic – Cambridge Enterprise 27 Jun 2024: Its team of nearly 200 employees were executing on its Phase II clinical trials for the treatment of geographic atrophy secondary to age-related macular degeneration, having generated positive clinical data

  4. Cambridge tech ecosystem soars to $191 billion in value – Cambridge…

    https://www.enterprise.cam.ac.uk/news/cambridge-tech-ecosystem-soars-to-191-billion-in-value/
    Thumbnail for Cambridge tech ecosystem soars to $191 billion in value – Cambridge Enterprise 12 Jun 2024: Pitching to a room of over 200 investors eager to find out more about their ground-breaking solutions, the cohort joined a line-up of speakers including University of Cambridge

  5. MAT2A inhibitors to treat BK polyomavirus disease

    https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=28102
    27 Jun 2024: Through next-generation sequencing,around 200 genes were found to be significantly associated with BKPyV infection.One of the most significant hits identified in the genome-wide screen was MAT2A(Figure
    By: Cambridge Enterprise

  6. MAT2A inhibitors to treat BK polyomavirus disease – Cambridge…

    https://www.enterprise.cam.ac.uk/opportunities/mat2a-inhibitors-to-treat-bk-polyomavirus-disease/
    Thumbnail for MAT2A inhibitors to treat BK polyomavirus disease – Cambridge Enterprise 19 Apr 2024: Through next-generation sequencing, around 200 genes were found to be significantly associated with BKPyV infection.

  7. Operations – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/about/our-team/operations/
    20 Mar 2024: Before joining Cambridge Enterprise, Ian played a pivotal role in the rapid expansion of Gearset, contributing to the growth from 70 to over 200 employees.

  8. FCO Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/fco/feed/
    26 Jun 2024: ccp-props="{"201341983":0,"335559739":200,"335559740":276}"/span/p p style="font-weight: 400;"Fortunately, many of those countries benefit from innovative, enthusiastic and committed researchers who are keen to ... 201341983":0,"335559739":200,"335559740"

  9. MIT Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/mit/feed/
    26 Jun 2024: 25.03.19-Russell-Cowburn-200-x-200-1.jpg"img decoding="async" class="size-full wp-image-12443 alignleft" ... uk/wp-content/uploads/2019/03/25.03.19-Russell-Cowburn-200-x-200.jpg" alt="" width="1" height="1" //aSurface Authentication’.

  10. Kazakhstan Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/kazakhstan/feed/
    26 Jun 2024: 0,"335559739":200,"335559740":276}"/span/p p style="font-weight: 400;"Kazakhstan, a vast country in central Asia, is perhaps best known as the home of the Baikonur space launch ... 335559739":200,"335559740":276}"/span/p p style="font-weight:

  11. Annual Review 2022 Contents Foreword From the Chair Investment ...

    https://www.enterprise.cam.ac.uk/wp-content/uploads/2024/03/Cambridge_Enterprise_2022_Annual_Review_FINAL-compressed_1.pdf
    26 Mar 2024: Its team of nearly 200 employees were executing on its Phase II clinical trials for the treatment of geographic atrophy secondary to age-related macular degeneration, having generated positive clinical data

Refine your results

Format

clear all

Date

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.